Study of the Effects of Negative Emotions on Endothelial Function
Status: | Active, not recruiting |
---|---|
Conditions: | Cardiology |
Therapuetic Areas: | Cardiology / Vascular Diseases |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 2/1/2019 |
Start Date: | September 1, 2013 |
End Date: | December 1, 2019 |
Translational Research of Negative Emotions and Acute Endothelial Dysfunction
Study aims and hypotheses are as follows:
Primary Hypotheses:
Compared to the neutral condition, the anger recall task will acutely induce endothelial
dysfunction by impairing endothelium-dependent arterial vasodilation (Hypothesis 1a);
increasing circulating levels of EC-derived microparticles (EMPs), a marker of EC injury
(Hypothesis 1b); and reducing circulating levels of bone marrow-derived endothelial
progenitor cells (EPCs), a marker of EC reparative capacity (Hypothesis 1c).
Secondary Hypotheses:
Compared to the neutral condition, the depressed mood and separately the anxiety recall tasks
will acutely impair endothelium-dependent arterial vasodilation, increase circulating levels
of EMPs, and reduce circulating levels of bone marrow-derived EPCs. There will be a relation
of the level of self-reported anger, depressed mood, and anxiety with endothelial
dysfunction.
Primary Hypotheses:
Compared to the neutral condition, the anger recall task will acutely induce endothelial
dysfunction by impairing endothelium-dependent arterial vasodilation (Hypothesis 1a);
increasing circulating levels of EC-derived microparticles (EMPs), a marker of EC injury
(Hypothesis 1b); and reducing circulating levels of bone marrow-derived endothelial
progenitor cells (EPCs), a marker of EC reparative capacity (Hypothesis 1c).
Secondary Hypotheses:
Compared to the neutral condition, the depressed mood and separately the anxiety recall tasks
will acutely impair endothelium-dependent arterial vasodilation, increase circulating levels
of EMPs, and reduce circulating levels of bone marrow-derived EPCs. There will be a relation
of the level of self-reported anger, depressed mood, and anxiety with endothelial
dysfunction.
Atherosclerosis-related cardiovascular disease (CVD) events remain the leading causes of
morbidity and mortality in industrialized nations. Atherosclerosis is a diffuse disease
characterized by the deposition of lipid and other blood-borne material within the arterial
wall. Evidence demonstrates that disruption of an arterial atherosclerotic plaque and
subsequent thrombus formation is responsible for the onset of CVD events. Cardiovascular
research efforts have been directed toward the identification of early underlying factors
that initiate this cascade.
It has been known for some time that the experience of negative emotions is associated with
an increased risk of incident CVD events, independent of traditional risk factors. Among the
best-studied negative emotions is anger. Population-based studies have demonstrated that the
experience of anger is a trigger of incident CVD events. The mechanism(s) by which provoked
anger acutely affects the pathways that underlie atherosclerosis development and progression
remain to be fully characterized.
Endothelial dysfunction is a promising mechanism that may explain the link between anger and
incident CVD events. Vascular endothelial cells (ECs) play essential roles in maintaining
vascular tone and the integrity of blood vessels. Evidence suggests that endothelial
dysfunction is an early pathogenic process underlying atherosclerosis development and CVD
event onset. Our preliminary findings show in apparently healthy individuals, an anger recall
task acutely induces endothelial dysfunction by impairing endothelium-dependent vasodilation,
injuring ECs, and disrupting the molecular processes underlying EC reparative capacity. We
have additionally found that this task may induce endogenous nitric oxide (NO) inhibition,
which plays a central role in aggravating endothelial dysfunction. Therefore, NO inhibition
may partially mediate anger-provoked endothelial dysfunction.
Although the strongest data are on anger-provoked CVD events, there is also some evidence
that the experience of other core negative emotions such as depressed mood and anxiety may
trigger CVD events. Whether the provocation of depressed mood and anxiety acutely induces
endothelial dysfunction and NO inhibition remains to be determined. The overall aim of this
study is to primarily examine the acute effects of provoked anger and secondarily depressed
mood and anxiety on EC health. We will also explore whether NO inhibition partially mediates
the acute effects of anger, depressed mood, and anxiety on endothelial function. Examination
of these critical pathways will help identify the biological pathways by which the experience
of core negative emotions leads to incident CVD risk.
To address these highly significant research questions, we propose a state-of-the-art,
laboratory-based, randomized controlled experiment in which 280 participants will be
randomized to one of four experimental conditions: an anger recall task (N=70), a depressed
mood recall task (N=70), an anxiety recall task (N=70), and an emotionally neutral condition
(N=70).
morbidity and mortality in industrialized nations. Atherosclerosis is a diffuse disease
characterized by the deposition of lipid and other blood-borne material within the arterial
wall. Evidence demonstrates that disruption of an arterial atherosclerotic plaque and
subsequent thrombus formation is responsible for the onset of CVD events. Cardiovascular
research efforts have been directed toward the identification of early underlying factors
that initiate this cascade.
It has been known for some time that the experience of negative emotions is associated with
an increased risk of incident CVD events, independent of traditional risk factors. Among the
best-studied negative emotions is anger. Population-based studies have demonstrated that the
experience of anger is a trigger of incident CVD events. The mechanism(s) by which provoked
anger acutely affects the pathways that underlie atherosclerosis development and progression
remain to be fully characterized.
Endothelial dysfunction is a promising mechanism that may explain the link between anger and
incident CVD events. Vascular endothelial cells (ECs) play essential roles in maintaining
vascular tone and the integrity of blood vessels. Evidence suggests that endothelial
dysfunction is an early pathogenic process underlying atherosclerosis development and CVD
event onset. Our preliminary findings show in apparently healthy individuals, an anger recall
task acutely induces endothelial dysfunction by impairing endothelium-dependent vasodilation,
injuring ECs, and disrupting the molecular processes underlying EC reparative capacity. We
have additionally found that this task may induce endogenous nitric oxide (NO) inhibition,
which plays a central role in aggravating endothelial dysfunction. Therefore, NO inhibition
may partially mediate anger-provoked endothelial dysfunction.
Although the strongest data are on anger-provoked CVD events, there is also some evidence
that the experience of other core negative emotions such as depressed mood and anxiety may
trigger CVD events. Whether the provocation of depressed mood and anxiety acutely induces
endothelial dysfunction and NO inhibition remains to be determined. The overall aim of this
study is to primarily examine the acute effects of provoked anger and secondarily depressed
mood and anxiety on EC health. We will also explore whether NO inhibition partially mediates
the acute effects of anger, depressed mood, and anxiety on endothelial function. Examination
of these critical pathways will help identify the biological pathways by which the experience
of core negative emotions leads to incident CVD risk.
To address these highly significant research questions, we propose a state-of-the-art,
laboratory-based, randomized controlled experiment in which 280 participants will be
randomized to one of four experimental conditions: an anger recall task (N=70), a depressed
mood recall task (N=70), an anxiety recall task (N=70), and an emotionally neutral condition
(N=70).
Inclusion Criteria:
- Age 18 and over
- Fluent in English
Exclusion Criteria:
- History of any chronic medical condition including prevalent CVD and traditional risk
factors
- Active smoking
- Chronic medication use, including over-the-counter drugs or herbal medications
- History of psychosis, a mood disorder, or any overt personality disorder
- Latex allergy
- Poor peripheral veins with low possibility of getting IV access
We found this trial at
1
site
630 W 168th St
New York, New York
New York, New York
212-305-2862

Principal Investigator: Daichi Shimbo, MD
Columbia University Medical Center Situated on a 20-acre campus in Northern Manhattan and accounting for...
Click here to add this to my saved trials
